Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Synta Pharmaceuticals Corp (NASDAQ:SNTA)

2.12
Delayed Data
As of Jul 31
 +0.02 / +0.95%
Today’s Change
1.85
Today|||52-Week Range
4.19
-20.00%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization169.0K167.0K169.0K169.0K
 
 
 
 
 
 
Operating ExpensesGross Income-169.0K-167.0K-169.0K-169.0K
 
 
 
 
 
General Expenses21.5M19.3M19.7M20.2M
 
 
 
 
 
Research And Development18.8M16.2M15.7M16.2M
 
 
 
 
 
Total Operating Expenses21.7M19.4M19.9M20.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-21.7M-19.4M-19.9M-20.3M
 
 
 
 
 
Interest Expense On Debt585.0K517.0K458.0K375.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-22.3M-20.0M-20.4M-20.7M
 
 
 
 
 
Net Income-22.3M-20.0M-20.4M-20.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS94.0M105.8M108.4M108.4M
 
 
 
 
 
Shares To Calculate EPS Diluted94.0M105.8M108.4M108.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.24-$0.19-$0.19-$0.19
 
 
 
 
 
EPS Diluted-$0.24-$0.19-$0.19-$0.19